Navigation Links
China Pharma Holdings, Inc. Will Attend the Susquehanna Financial Group, LLP (SIG) 'Beijing Management Summit'
Date:9/1/2008

HAIKOU, Hainan, China, Sept. 1 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and branded bio/pharmaceutical products in China, today announced attendance at the Susquehanna Financial Group, LLP (SIG)"Beijing Management Summit" held in Beijing, PRC, from the 10th to the 12th of September 2008.

Attending this conference and available for one-on-one meetings with analysts and investors throughout the conference will be senior management from the company including the President and CEO, Ms Zhilin Li, and the CFO, Mr Xinhua Wu.

Ms Zhilin Li has been CEO of China Pharma since 2005. She also founded and has been CEO of Hainan Helpson Medicine & Biotechnique Ltd. (Helpson; a wholly owned subsidiary of China Pharma Holdings, Inc.) since 1993. Mr Xinhua Wu has been CFO of Helpson since 1999 and CFO of China Pharma since 2005.

Management will discuss the Company's current product portfolio, development pipeline, research and development platform, recent financial highlights and growth strategy.

For more information on the conference, please visit the SIG website.

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. develops, manufactures, and markets generic and brand bio/pharmaceutical products in China that treat a wide range of conditions, including infections, liver disease, cardio/cerebrovascular and CNS diseases, and other prevalent diseases.

Helpson is a specialty pharmaceutical company headquartered in Haikou City, Hainan Province, China.

For more information, please contact:

Diana

China Pharma Holdings, Inc.

Tel: +86-898-6681-1730

Fax: +86-898-6681-9024

Email: hps@chinapharmaholdings.com


'/>"/>
SOURCE China Pharma Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 Eutilex Co. Ltd. today announced that ... Series A financing. This financing round included participation from ... SNU Bio Angel. This new funding brings the total ... $27.7M) since its founding in 2015. ... and commercialization of its immuno-oncology programs, expand its R&D ...
(Date:12/8/2016)... 2016   Biocept, Inc . (NASDAQ: ... clinically actionable liquid biopsy tests to improve the ... featuring its Target Selector™ Circulating Tumor Cell platform ... detection of actionable biomarkers in patients with metastatic ... Sara Cannon Research Institute (SCRI), the research arm ...
(Date:12/7/2016)... McLean, VA (PRWEB) , ... December 07, 2016 ... ... peer-reviewed medical journal has concluded that “in the setting of previously treated, advanced ... Further refinement in defining the optimal patient population and timing of blood sampling ...
(Date:12/7/2016)... LANSING, Mich. , Dec. 7, 2016 ... it has named Dr. Dan Kephart as ... the company. Kephart will assume his responsibilities at Neogen ... research and development director for the agribusiness unit of ... food safety development at Life Technologies. His extensive industry ...
Breaking Biology Technology:
(Date:11/19/2016)... , Nov. 18, 2016 Securus Technologies, ... solutions for public safety, investigation, corrections and monitoring, announced ... smaller competitor, ICSolutions, to have an independent technology judge ... the most modern high tech/sophisticated telephone calling platform, and ... customers that they do most of what we do ...
(Date:11/17/2016)... OF INDUSTRY, Calif. , Nov. 17, 2016  AIC announces that it has ... using NVMe storage servers in organizations that require high-performance scale-out plus high speed data transfer storage ... ... ... Setting up ...
(Date:11/15/2016)...  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... gut microbiome, today announced the pricing of an ... common stock and warrants to purchase 50,000,000 shares ... the public of $1.00 per share and accompanying ... offering, excluding the proceeds, if any from the ...
Breaking Biology News(10 mins):